On 03.07.2018 EFSA opened a public consultation on the RAR for ziram. On 03.07.2018 EFSA opened a public consultation on the RAR for ziram. Italy is the RMS for this AIR 3.4 substance. This is the...
EFSA conclusions fosetyl published
EFSA published on 03.07.2018 (report 5307) the conclusions on the peer review of fosetyl.
New Peer Review Expert meetings scheduled
EFSA published the agenda for the peer review expert meetings for July-September.
EFSA pyriproxyfen consultation
pyriproxyfen: on 08.05.2018 EFSA initiated the public consultation on the RAR drafted by RMS Netherlands. The RAR is based on a renewal dossier submitted by Sumitomo. The submission is based on the...
EFSA peer review spinosad
spinosad; publ. 03.05.2018, report 5252 EFSA published its conclusions on the peer review of this AIR 3.8 substance. The conclusions are based on the dossier of October 2015 from Dow, based on...
EFSA peer review asulam
EFSA published on 20.04.2018 its conclusions on the peer review of asulam-sodium (report 5251). The EFSA conclusions on the peer review are based on the dossier submitted by UPL, based on...
EFSA peer review conclusions trinexapac-ethyl
EFSA published its conclusions on the peer review of trinexapac-ethyl.
EFSA conclusions dimethenamid-P
EFSA published on 12.04.2018 (report 5211) the conclusions on the peer review of dimethenamid-P.
EFSA consultation propamocarb
This consultation was once scheduled to start 06.08.2017. It took a bit longer: on 04.04.2018 EFSA initiated the public consultation for propamocarb, based on the RAR (dated June 2017) drafted by RMS...
EFSA conclusions tolclofos-methyl
EFSA published on 29.01.2018 the conclusions on the peer review of tolclofos-methyl (report 5130) EFSA identified no safe use. A list of 23 data-gaps resulted in 2 issues that could not be finalised...